| Original language | English (US) |
|---|---|
| Pages (from-to) | 2322 |
| Number of pages | 1 |
| Journal | Journal of Allergy and Clinical Immunology |
| Volume | 141 |
| Issue number | 6 |
| DOIs | |
| State | Published - Jun 2018 |
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Journal of Allergy and Clinical Immunology, Vol. 141, No. 6, 06.2018, p. 2322.
Research output: Contribution to journal › Letter › peer-review
}
TY - JOUR
T1 - Additional oral food challenge considerations
AU - Bird, J. Andrew
AU - Fleischer, David M.
AU - Groetch, Marion
AU - Nowak-Węgrzyn, Anna
AU - Sicherer, Scott
AU - Young, Michael C.
N1 - Funding Information: Disclosure of potential conflict of interest: J. A. Bird has received personal fees from Food Allergy Research and Education, Aimmune Therapeutics, and DBV Technologies, and has received grants from Aimmune Therapeutics and DBV Technologies. D. M. Fleischer has received travel support from the American College of Allergy, Asthma, and Immunology and Nestle Nutrition; is on the scientific advisory council for the National Peanut Board; serves on the FAACT Medical Advisory Board and FARE Clinical Advisory Board; has consultant arrangements with DBV Technologies, Aimmune Therapeutics, Monsanto, Kaleo Pharma, INSYS Therapeutics, and BEFORE Brands; is employed by University of Colorado Medicine; has received grants from Nestle Nutrition Institute, DBV Technologies, and Aimmune Therapeutics; has received payment for lectures from Nestle Nutrition Institute and the American College of Allergy, Asthma, and Immunology; has received payment for manuscript preparation from the Nestle Nutrition Institute; and has received royalties from UpToDate. M. Groetch has received personal fees from Nutricia North America and Mead Johnson. A. Nowak-Węgrzyn has received grants from the National Institutes of Health/National Institute of Allergy and Infectious Diseases, DBV Technologies, Astellas Pharma, Nutricia, Nestle, and Thermo Fisher, and has received personal fees from Nutricia, Nestle, Thermofisher, Merck, and UpToDate. S. Sicherer has received personal fees from UpToDate, Johns Hopkins University Press, and the American Academy of Allergy, Asthma & Immunology and has received grants from the National Institutes of Health/National Institute of Allergy and Infectious Diseases and HAL Allergy. M. C. Young declares no relevant conflicts of interest.
PY - 2018/6
Y1 - 2018/6
UR - http://www.scopus.com/inward/record.url?scp=85047389828&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047389828&partnerID=8YFLogxK
U2 - 10.1016/j.jaci.2018.02.037
DO - 10.1016/j.jaci.2018.02.037
M3 - Letter
C2 - 29692338
AN - SCOPUS:85047389828
SN - 0091-6749
VL - 141
SP - 2322
JO - Journal of Allergy and Clinical Immunology
JF - Journal of Allergy and Clinical Immunology
IS - 6
ER -